正面交锋分析：Elekta AB（Publ）（OTCMKTS: EKTAY）VS收购医疗科技（纳斯达克股票代码：MTAC）

Elekta AB (publ) (OTCMKTS:EKTAY – Get Rating) and MedTech Acquisition (NASDAQ:MTAC – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.

Profitability

This table compares Elekta AB (publ) and MedTech Acquisition's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Elekta AB (publ) and MedTech Acquisition's revenue, earnings per share and valuation.

Elekta AB (publ) has higher revenue and earnings than MedTech Acquisition.

Insider and Institutional Ownership

74.9% of MedTech Acquisition shares are owned by institutional investors. 41.3% of Elekta AB (publ) shares are owned by company insiders. Comparatively, 20.0% of MedTech Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Elekta AB (publ) and MedTech Acquisition, as reported by MarketBeat.com.

Elekta AB (publ) currently has a consensus target price of $65.50, indicating a potential upside of 707.64%. Given Elekta AB (publ)'s higher possible upside, analysts clearly believe Elekta AB (publ) is more favorable than MedTech Acquisition.

Risk and Volatility

Elekta AB (publ) has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, MedTech Acquisition has a beta of -0.03, suggesting that its share price is 103% less volatile than the S&P 500.

Summary

Elekta AB (publ) beats MedTech Acquisition on 9 of the 10 factors compared between the two stocks.

About Elekta AB (publ)

(Get Rating)

Elekta AB operates as a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America, Europe, Middle East and Africa and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

About MedTech Acquisition

(Get Rating)

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.